Pleural mesothelioma: combined modality treatments
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 13, 217-225
- https://doi.org/10.1093/annonc/mdf663
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesotheliomaCancer, 1997
- Evaluation of pleural diseases with FDG-PET imaging: preliminary reportThorax, 1997
- Patterns of Failure After Trimodality Therapy for Malignant Pleural MesotheliomaThe Annals of Thoracic Surgery, 1997
- Combination chemotherapy with cisplatin-vinblastine in malignant mesotheliomaLung Cancer, 1994
- Treatment of Malignant Pleural Mesothelioma with Cisplatin, Mitomycin C and Alpha InterferonOncology, 1994
- Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1991
- Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II studyCancer, 1991
- A phase II study of pirarubicin in malignant pleural mesotheliomaCancer, 1990
- A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesotheliomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycinCancer, 1984